TG Therapeutics's total assets for Q1 2026 were $1.53B, an increase of 43.79% from the previous quarter. TGTX total liabilities were $945.71M for the fiscal quarter, a 127.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.